PTC Therapeutics to Present at Upcoming Conference
Recently, PTC Therapeutics, Inc. (NASDAQ: PTCT) revealed that its Chief Executive Officer, Matthew B. Klein, M.D., will present at a significant healthcare event. This will take place during the 44th Annual J.P. Morgan Healthcare Conference. The scheduled slot for PTC's presentation is on January 12, 2026, at 9 a.m. PST, which is 12 p.m. EST.
Details of the Presentation
The presentation will be accessible through a live webcast, which can be found on the Investors section of PTC Therapeutics' official website. Participants can look forward to a comprehensive discussion of the company's vision and pipeline of medicines. It’s significant to note that this session will be archived for 30 days, allowing for later viewing by interested stakeholders.
About PTC Therapeutics
PTC Therapeutics is making waves in the biopharmaceutical industry with its focus on developing unique medicines for patients with rare diseases. The company operates on the mission of delivering access to innovative treatments that fulfill significant medical needs not yet addressed in the market. PTC is dedicated to harnessing its scientific capabilities and expanding its global commercial footprint to maximize benefits for patients and those involved in their care.
As part of its strategy, PTC continues to strengthen a diversified pipeline of transformative therapeutics, dedicated to enhancing the quality of life for patients across various age groups.
Engaging with PTC Therapeutics
To learn more about PTC Therapeutics and their advancements, the community is encouraged to visit their official website. The company actively engages on multiple platforms, including LinkedIn, X, Facebook, and Instagram, showcasing their commitment to transparency and connection with the public.
Contact Information
For those requiring further details regarding investor relations, they can reach Ellen Cavaleri at +1 (615) 618-6228. Additionally, for media inquiries, Jeanine Clemente is available at +1 (908) 912-9406 for responsive assistance.
Frequently Asked Questions
What event is PTC Therapeutics participating in?
PTC Therapeutics will present at the 44th Annual J.P. Morgan Healthcare Conference.
Who is presenting for PTC Therapeutics?
CEO Matthew B. Klein, M.D., will be the presenter at the conference.
When is the presentation scheduled?
The presentation is scheduled for January 12, 2026, at 9 a.m. PST/12 p.m. EST.
How can people access the presentation?
The presentation will be available via live webcast on PTC Therapeutics' website.
How can investors contact PTC Therapeutics?
Investors can contact Ellen Cavaleri at +1 (615) 618-6228 for any inquiries regarding PTC Therapeutics.